When the Centers for Disease Control and Prevention’s vaccine committee voted last week to change decades of guidance over Hepatitis B vaccines for children, several committee members referenced the approach in Denmark and other European nations. But experts warn that the system is not replicable in the U.S.
Host Robin Young speaks to professor Beate Kampmann, director of the Centre for Global Health at the Charité University of Medicine, Berlin, for more.
This article was originally published on WBUR.org.
Copyright 2025 WBUR
